企業プロフィール
Integra LifeSciences 株価・ニュース・カタリスト
- ティッカー:
- IART
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
17.66 USD (-3.71%)
終値
最終更新: 2026年8月17日
1.22B USD
時価総額
株価変動の要因
As of Aug 17, 2026, IART closed down 3.71% at $17.66. No new same-company headline was identified in the current news window.
企業概要
Medical Technology Portfolio
Integra LifeSciences develops medical technologies used in neurosurgery, reconstructive surgery and wound care. Its products support procedures in which tissue protection, repair and regeneration are critical to patient outcomes.
Neurosurgical Technologies
The company supplies instruments, implants and systems used in neurosurgery and neurocritical care. These products include technologies for dural repair, intracranial pressure management, tissue ablation and precision surgical access.
Tissue and Wound Reconstruction
Integra’s regenerative-tissue portfolio includes products used for soft-tissue reinforcement, wound closure and surgical reconstruction. SurgiMend is a biologic matrix intended to return to production from the company’s Braintree manufacturing facility.
今後のカタリスト
- Start of SurgiMend production at the Braintree facility targeted by the end of June 2026.
- Relaunch of SurgiMend expected in the fourth quarter of 2026.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。